Anti-FAD1/ FLAD1/ FADS monoclonal antibody

Anti-FAD1/ FLAD1/ FADS antibody for FACS & in-vivo assay

Target products collectionGo to FLAD1/FLAD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2124-Ab-1/ GM-Tg-hg-MP2124-Ab-2Anti-Human FLAD1 monoclonal antibodyHuman
GM-Tg-rg-MP2124-Ab-1/ GM-Tg-rg-MP2124-Ab-2Anti-Rat FLAD1 monoclonal antibodyRat
GM-Tg-mg-MP2124-Ab-1/ GM-Tg-mg-MP2124-Ab-2Anti-Mouse FLAD1 monoclonal antibodyMouse
GM-Tg-cynog-MP2124-Ab-1/ GM-Tg-cynog-MP2124-Ab-2Anti-Cynomolgus/ Rhesus macaque FLAD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2124-Ab-1/ GM-Tg-felg-MP2124-Ab-2Anti-Feline FLAD1 monoclonal antibodyFeline
GM-Tg-cang-MP2124-Ab-1/ GM-Tg-cang-MP2124-Ab-2Anti-Canine FLAD1 monoclonal antibodyCanine
GM-Tg-bovg-MP2124-Ab-1/ GM-Tg-bovg-MP2124-Ab-2Anti-Bovine FLAD1 monoclonal antibodyBovine
GM-Tg-equg-MP2124-Ab-1/ GM-Tg-equg-MP2124-Ab-2Anti-Equine FLAD1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2124-Ab-1/ GM-Tg-hg-MP2124-Ab-2; GM-Tg-rg-MP2124-Ab-1/ GM-Tg-rg-MP2124-Ab-2;
GM-Tg-mg-MP2124-Ab-1/ GM-Tg-mg-MP2124-Ab-2; GM-Tg-cynog-MP2124-Ab-1/ GM-Tg-cynog-MP2124-Ab-2;
GM-Tg-felg-MP2124-Ab-1/ GM-Tg-felg-MP2124-Ab-2; GM-Tg-cang-MP2124-Ab-1/ GM-Tg-cang-MP2124-Ab-2;
GM-Tg-bovg-MP2124-Ab-1/ GM-Tg-bovg-MP2124-Ab-2; GM-Tg-equg-MP2124-Ab-1/ GM-Tg-equg-MP2124-Ab-2
Products NameAnti-FLAD1 monoclonal antibody
Formatmab
Target NameFLAD1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FLAD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FAD1/ FLAD1/ FADS VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2124
    Target NameFLAD1
    Gene ID80308,319945,751787,717133,490438,101092414,506682,100063090
    Gene Symbol and SynonymsA930017E24Rik,FAD1,FADS,FLAD1,LSMFLAD,PP591
    Uniprot AccessionQ8NFF5
    Uniprot Entry NameFAD1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160688
    Target ClassificationN/A

    The target: FLAD1, gene name: FLAD1, also named as FAD1, FADS, LSMFLAD, PP591. This gene encodes the enzyme that catalyzes adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.